SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-19-036718
Filing Date
2019-10-09
Accepted
2019-10-09 17:14:36
Documents
12
Period of Report
2019-10-03
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K fgen-8k_20191003.htm   iXBRL 8-K 42939
  Complete submission text file 0001564590-19-036718.txt   171553

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA fgen-20191003.xsd EX-101.SCH 6196
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE fgen-20191003_lab.xml EX-101.LAB 19065
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE fgen-20191003_pre.xml EX-101.PRE 11718
14 EXTRACTED XBRL INSTANCE DOCUMENT fgen-8k_20191003_htm.xml XML 3404
Mailing Address 409 ILLINOIS STREET SAN FRANCISCO CA 94158
Business Address 409 ILLINOIS STREET SAN FRANCISCO CA 94158 415-978-1200
FIBROGEN INC (Filer) CIK: 0000921299 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36740 | Film No.: 191144899
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences